Our dental practice is now pleased to accelerate your recovery from numbness after routine dental procedures. OraVerse™ is the first and only product of its kind to rapidly reverse the effects of local anesthetics containing a vasoconstrictor so you can feel, speak, smile, and drink normally in approximately half the time. 1 OraVerse is not recommended for use in children less than 6 years of age or weighing less than 15 kg (33 lbs). 
 
For more information on this innovative new product, we invite you to visit the OraVerse Website.
 
Important Safety Information
Tachycardia, bradycardia, and cardiac arrhythmias may occur with the use of phentolamine or other alpha-adrenergic blocking agents. Although such effects are uncommon with OraVerse (phentolamine mesylate), clinicians should be alert to the signs and symptoms of these events, particularly in patients with a history of cardiovascular disease. Following parenteral use of phentolamine at doses between 5 to 15 times higher than the recommended dose of OraVerse, myocardial infarction, and cerebrovascular spasm and occlusion have been reported, usually in association with marked hypotensive episodes producing shock-like states.
 
1 Median time to recovery of normal sensation was reduced by 85 minutes (55%) in the mandible and by 83 minutes (62%) in the maxilla compared to control. Median time to recovery of normal function was reduced by 60 minutes (50%) in the mandible and by 45 minutes (43%) in the maxilla.